维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Smoot RL"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Postoperative hematoma following inguinal herniorrhaphy: patient characteristics leading to increased risk显示文摘	Smoot RL Oderich GS Taner CB	2008	Hernia2008，12，3：	1
2	miR-25 targets TNF-re- lated apoptosis inducing ligand (TRAIL) death receptor-4 and pro- motes apoptosis resistance in cholangiocarcinoma 显示文摘	Razumilava N Bronk SF Smoot RL	2012	Hepatology2012，55，2：	1
3	An innovative option for venous reconstruction after pancreaticoduodenectomy:the left renal vein显示文摘	Smoot RL Christein JD Farnell MB	2007	J Gastrointest Surg2007，11，4：	1
4	Durability of portal venous reconstruction following resection during pancreaticoduodenectomy 显示文摘	Smoot RL Christein JD Faruell MB	2006	J Gastrointest Surg2006，10，10：	1
5	Central pancreatectomy: a technique for the resection of pancreatic neck lesions显示文摘	ChristeinJD Smoot RL Farnell MB	2006	Arch Surg2006，141，3：	1
6	Modified Appleby procedure for resection of tumors of the pancreatic body and tail with celiac axis involvement显示文摘	Smoot RL Donohue JH	2012	J Gastrointest Surg2012，16，11：	1
7	miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma显示文摘	Razumilava N Bronk SF Smoot RL	2012	Hepatology2012，55，2：	1
8	miR-25 targets TNF- related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma 显示文摘	Razumilava N Bronk SF Smoot RL	2011	Hepatology2011，55，2：	1
9	miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinonm 显示文摘	Razumilava N Bronk SF Smoot RL	2012	Hepatology2012，55，2：	1
10	miR-25 Targets TRAILDeath Receptor-4 and Promotes Apoptosis Resistance inCholangiocarcinoma显示文摘	Razumilava N Bronk SF Smoot RL	2012	Hepatology (Baltimore Md)2012，55，2：	1
11	Resection of hepatocellular carcinoma in patients without cirrhosis显示文摘	Smoot RL Nagorney DM Chandan VS		0，，：	1
12	An innovative option for venous reconstruction after pancreaticoduodenectomy: the left renal vein显示文摘	Smoot RL Christein JD Farnell MB	2007	J Gastrointest Surg2007，11，4：	1
13	Non-canonical Hedgehog signaling contributes to chemotaxis in cholangiocarcinoma 显示文摘	Razumilava N Gradilone SA Smoot RL	2014	J Hepatol2014，60，3：	1
14	Adenosquamous carcinoma of the pancreas:a single-institution experience comparing resection and palliative care显示文摘	Smoot RL Zhang L Sebo TJ	2008	J Am Coll Surg2008，207，3：	1
15	Central pancreatectomy:a technique for the resectlon of pancreatic neck lesions显示文摘	Christein JD Smoot RL Famell MB	2006	Arch Surg2006，141，3：	1
16	Adenosquamous carcinoma of the pancreas, a single-institution experience comparing resection and palliative care显示文摘	Smoot RL Zhang L Sebo TJ	2008	J Am Coll Surg2008，207，3：	1
17	Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2显示文摘	Blechacz BRA Smoot RL Bronk SF		0，，06：	1
18	miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma 显示文摘	RAZUMILAVA N BRONK SF SMOOT RL	2012	Hepatology2012，55，2：	1
19	Sorafenib inhibits signal transducer and activator of transcription - 3 signa?ling in cholangiocarcinoma cells by activating the phospha?tase shatterproof 2显示文摘	Blechacz BR Smoot RL Bronk SF	2009	Hepatology2009，50，6：	1
20	Centralpancreatectomy: a technique for the resection of pancreaticneck lesions 显示文摘	Christein JD Smoot RL Farnell MB	2006	Arch Surg2006，141，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示